NCT04237935View on ClinicalTrials.gov

Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data

CompletedOBSERVATIONAL
Enrollment

27,960

Participants

Timeline

Start Date

September 22, 2019

Primary Completion Date

February 18, 2021

Study Completion Date

February 18, 2021

Conditions
Antiplatelet
Interventions
DRUG

Ticagrelor 90mg

Ticagrelor 90 mg dispensing claim is used as the exposure group

DRUG

Clopidogrel 75mg

Clopidogrel 75 mg dispensing claim is used as the reference group

Trial Locations (1)

02120

Brigham And Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT04237935 - Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data | Biotech Hunter | Biotech Hunter